Literature DB >> 31450125

Identification and medical utilization of newly diagnosed panic disorder: A Nationwide case-control study.

Hu-Ming Chang1, Chun-Hung Pan2, Pao-Huan Chen3, Yi-Lung Chen1, Sheng-Shiang Su1, Shang-Ying Tsai3, Chiao-Chicy Chen4, Chian-Jue Kuo5.   

Abstract

OBJECTIVE: Ascertaining comorbid illnesses and patterns of medical utilization early in the course of psychiatric illness can help identify patients with panic disorder. We investigated how such cases were diagnosed and the comorbidities associated with newly diagnosed panic disorder in a nationwide database.
METHODS: We enrolled a large representative cohort of the general population in Taiwan (N = 1000,000) and selected 9759 cases of panic disorder from January 1, 2000 to December 31, 2013. The distribution of the departments in which the cases were identified and the medical utilization 12 months before diagnosis were analyzed. Based on a nested case-control study, four controls were randomly selected for each case and matched for sex, age, and incidence year. Conditional logistic regression was used to explore the factors associated with newly-diagnosed panic disorder such as demographic factors, concomitant medications, and physical and psychiatric comorbidities.
RESULTS: Most (58.5%) cases of panic disorder were diagnosed in the psychiatry department, whereas only 3.7% were identified in the emergency department. Before diagnosis, the patients frequently visited the departments of internal medicine, family practice, and Chinese herbal medicine. A multivariate analysis revealed a higher number of physical and psychiatric comorbidities before diagnosis in the cases compared with the controls, especially depressive disorder and other anxiety disorders.
CONCLUSIONS: Individuals with certain comorbidities and patterns of medical utilization are more likely to be diagnosed with panic disorder. We suggest providing more training to general practitioners and emergency physicians for the early diagnosis of panic disorder.
Copyright © 2019 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Comorbidity; Medical expenditure; Medical utilization; Panic disorder

Year:  2019        PMID: 31450125     DOI: 10.1016/j.jpsychores.2019.109815

Source DB:  PubMed          Journal:  J Psychosom Res        ISSN: 0022-3999            Impact factor:   3.006


  4 in total

1.  Videoconferencing Psychotherapy for Panic Disorder and Agoraphobia: Outcome and Treatment Processes From a Non-randomized Non-inferiority Trial.

Authors:  Stéphane Bouchard; Micheline Allard; Geneviève Robillard; Stéphanie Dumoulin; Tanya Guitard; Claudie Loranger; Isabelle Green-Demers; André Marchand; Patrice Renaud; Louis-Georges Cournoyer; Giulia Corno
Journal:  Front Psychol       Date:  2020-08-21

2.  Panic Attack Prediction Using Wearable Devices and Machine Learning: Development and Cohort Study.

Authors:  Chan-Hen Tsai; Pei-Chen Chen; Ding-Shan Liu; Ying-Ying Kuo; Tsung-Ting Hsieh; Dai-Lun Chiang; Feipei Lai; Chia-Tung Wu
Journal:  JMIR Med Inform       Date:  2022-02-15

Review 3.  Panic disorder in general medical practice- A narrative review.

Authors:  Narayana Manjunatha; Dushad Ram
Journal:  J Family Med Prim Care       Date:  2022-03-10

4.  Associations between brain-derived neurotrophic factor and cognitive impairment in panic disorder.

Authors:  Wenchen Wang; Yuanyuan Liu; Shuqing Luo; Xiaoyun Guo; Xingguang Luo; Yong Zhang
Journal:  Brain Behav       Date:  2020-10-12       Impact factor: 2.708

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.